|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 8.300 USD | -0.12% |
|
+1.22% | -28.63% |
Company Valuation: CorMedix Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 173.2 | 174.1 | 206 | 491.5 | 916.3 | 646.9 | - | - |
| Change | - | 0.53% | 18.32% | 138.57% | 86.44% | -29.4% | - | - |
| Enterprise Value (EV) | 107.7 | 115.3 | 130 | 439.8 | 912.4 | 646.9 | 646.9 | 646.9 |
| Change | - | 7.05% | 12.71% | 238.36% | 107.46% | -29.1% | 0% | 0% |
| P/E | -6.07x | -5.7x | -4.13x | -27x | 5.7x | 17x | 138x | 18.8x |
| PBR | 2.76x | - | 2.94x | - | 2.3x | - | - | - |
| PEG | - | 4.28x | -0.2x | 0.4x | -0x | -0.2x | -1.6x | 0x |
| Capitalization / Revenue | 907x | 2,662x | - | 11.3x | 2.94x | 1.92x | 2.26x | 1.87x |
| EV / Revenue | 0x | 0x | - | 0x | 0x | 1.92x | 2.26x | 1.87x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | 0x | 7.63x | 52.4x | 13.4x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.75 | -0.74 | -0.91 | -0.3 | 2.04 | 0.488 | 0.06 | 0.4425 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.1909 | 0.0654 | - | 43.47 | 311.7 | 337.1 | 286.5 | 345.3 |
| EBITDA | - | - | - | -14.89 | 195.1 | - | - | - |
| EBIT 1 | -29.44 | -30.62 | -48.96 | -22.36 | 150.1 | 84.74 | 12.35 | 48.24 |
| Net income 1 | -28.21 | -29.7 | -46.34 | -17.93 | 163.1 | 45.66 | 5.686 | 42.78 |
| Net Debt | -65.47 | -58.79 | -76.03 | -51.69 | -3.905 | - | - | - |
| Reference price 2 | 4.550 | 4.220 | 3.760 | 8.100 | 11.630 | 8.300 | 8.300 | 8.300 |
| Nbr of stocks (in thousands) | 38,065 | 41,260 | 54,790 | 60,677 | 78,789 | 77,944 | - | - |
| Announcement Date | 3/29/22 | 3/30/23 | 3/12/24 | 3/25/25 | 3/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.01x | - | - | - | 647M | |
| 108.04x | 6.02x | 25.53x | 2.3% | 366B | |
| 23.54x | 3.2x | 11.19x | 1.68% | 70.76B | |
| 14.62x | 7.18x | 11x | - | 11.96B | |
| 17x | 2.19x | 7.45x | 2.61% | 8.72B | |
| 20.89x | 6.55x | 17.44x | -.--% | 5B | |
| 42.63x | 2.67x | 30.49x | 0.67% | 4.59B | |
| 36.37x | 5.67x | 16.61x | - | 3.16B | |
| -218.65x | - | - | -.--% | 2.54B | |
| Average | 6.83x | 4.78x | 17.10x | 1.21% | 52.6B | |
| Weighted average by Cap. | 87.46x | 5.52x | 22.57x | 2.16% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRMD Stock
- Valuation CorMedix Inc.
Select your edition
All financial news and data tailored to specific country editions
